Cargando…

Identification of glutamyl-prolyl-tRNA synthetase as a new therapeutic target in hepatocellular carcinoma via a novel bioinformatic approach

BACKGROUND: Hepatocellular carcinoma (HCC) has a high incidence, and current treatments are ineffective. We aimed to explore potential diagnostic and prognostic biomarkers for HCC by conducting bioinformatics analysis on genomic and proteomic data. METHODS: Genome and proteome data were downloaded f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shu, Jinyong, Luo, Pan, Zhang, Guifeng, Gao, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186547/ https://www.ncbi.nlm.nih.gov/pubmed/37201074 http://dx.doi.org/10.21037/jgo-23-247

Ejemplares similares

Phosphocode-dependent glutamyl-prolyl-tRNA synthetase 1 signaling in immunity, metabolism, and disease
por: Lee, Eun-Young, et al.
Publicado: (2023)

Glutamyl-prolyl-tRNA synthetase 1 coordinates early endosomal anti-inflammatory AKT signaling
por: Lee, Eun-Young, et al.
Publicado: (2022)

Origin and Evolution of Glutamyl-prolyl tRNA Synthetase WHEP Domains Reveal Evolutionary Relationships within Holozoa
por: Ray, Partho Sarothi, et al.
Publicado: (2014)

Cardiomyocyte-specific Loss of Glutamyl-prolyl-tRNA Synthetase Leads to Disturbed Protein Homeostasis and Dilated Cardiomyopathy
por: Wu, Jiangbin, et al.
Publicado: (2023)

Bacterial Aspartyl-tRNA Synthetase Has Glutamyl-tRNA Synthetase Activity
por: Rathnayake, Udumbara M., et al.
Publicado: (2019)

Glutamyl-Prolyl-tRNA Synthetase Regulates Epithelial Expression of Mesenchymal Markers and Extracellular Matrix Proteins: Implications for Idiopathic Pulmonary Fibrosis
por: Song, Dae-Geun, et al.
Publicado: (2018)

Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma
por: Kurata, Keiji, et al.
Publicado: (2023)

Correction: Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma
por: Kurata, Keiji, et al.
Publicado: (2023)

Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase
por: Keller, Tracy L., et al.
Publicado: (2012)

tRNA(Glu) Increases the Affinity of Glutamyl-tRNA Synthetase for Its Inhibitor Glutamyl-Sulfamoyl-Adenosine, an Analogue of the Aminoacylation Reaction Intermediate Glutamyl-AMP: Mechanistic and Evolutionary Implications
por: Blais, Sébastien P., et al.
Publicado: (2015)

Evolution of acceptor stem tRNA recognition by class II prolyl-tRNA synthetase
por: An, Songon, et al.
Publicado: (2008)

Control of fibrosis with enhanced safety via asymmetric inhibition of prolyl‐tRNA synthetase 1
por: Yoon, Ina, et al.
Publicado: (2023)

Babesia bovis: A bipartite signal directs the glutamyl-tRNA synthetase to the apicoplast
por: Pedroni, Monica J., et al.
Publicado: (2012)

Dispensability of zinc and the putative zinc-binding domain in bacterial glutamyl-tRNA synthetase
por: Chongdar, Nipa, et al.
Publicado: (2015)

Crystal structures of glutamyl-tRNA synthetase from Elizabethkingia anopheles and E. meningosepticum
por: Brooks, Lauryn, et al.
Publicado: (2022)

Elucidating the path to Plasmodium prolyl-tRNA synthetase inhibitors that overcome halofuginone resistance
por: Tye, Mark A., et al.
Publicado: (2022)

Recognition of tRNA(Gln) by Helicobacter pylori GluRS2—a tRNA(Gln)-specific glutamyl-tRNA synthetase
por: Chang, Keng-Ming, et al.
Publicado: (2010)

Recognition of tRNA(Gln) by Helicobacter pylori GluRS2—a tRNA(Gln)-specific glutamyl-tRNA synthetase
por: Chang, Keng-Ming, et al.
Publicado: (2009)

Correction: tRNAGlu Increases the Affinity of Glutamyl-tRNA Synthetase for Its Inhibitor Glutamyl-Sulfamoyl-Adenosine, an Analogue of the Aminoacylation Reaction Intermediate Glutamyl-AMP: Mechanistic and Evolutionary Implications
por: Blais, Sébastien P., et al.
Publicado: (2015)

Targeting prolyl-tRNA synthetase via a series of ATP-mimetics to accelerate drug discovery against toxoplasmosis
por: Yogavel, Manickam, et al.
Publicado: (2023)

Structure of an archaeal non-discriminating glutamyl-tRNA synthetase: a missing link in the evolution of Gln-tRNA(Gln) formation
por: Nureki, Osamu, et al.
Publicado: (2010)

Strictly Conserved Lysine of Prolyl-tRNA Synthetase Editing Domain Facilitates Binding and Positioning of Misacylated tRNA(Pro)
por: Bartholow, Thomas G., et al.
Publicado: (2014)

The zinc-binding domain of mammalian prolyl-tRNA synthetase is indispensable for catalytic activity and organism viability
por: Vasu, Kommireddy, et al.
Publicado: (2021)

Whole exome sequencing reveals mutations in NARS2 and PARS2, encoding the mitochondrial asparaginyl-tRNA synthetase and prolyl-tRNA synthetase, in patients with Alpers syndrome
por: Sofou, Kalliopi, et al.
Publicado: (2015)

Biochemical and Structural Characterization of Selective Allosteric Inhibitors of the Plasmodium falciparum Drug Target, Prolyl-tRNA-synthetase
por: Hewitt, Stephen Nakazawa, et al.
Publicado: (2016)

Discovery and pharmacological characterization of a new class of prolyl-tRNA synthetase inhibitor for anti-fibrosis therapy
por: Shibata, Akira, et al.
Publicado: (2017)

Double drugging of prolyl-tRNA synthetase provides a new paradigm for anti-infective drug development
por: Manickam, Yogavel, et al.
Publicado: (2022)

Adenosine-Mimicking Derivatives of 3-Aminopyrazine-2-Carboxamide: Towards Inhibitors of Prolyl-tRNA Synthetase with Antimycobacterial Activity
por: Pallabothula, Vinod Sukanth Kumar, et al.
Publicado: (2022)

Safety, tolerability, pharmacokinetic/pharmacodynamic characteristics of bersiporocin, a novel prolyl‐tRNA synthetase inhibitor, in healthy subjects
por: Park, Min Young, et al.
Publicado: (2023)

Identification of Selective Novel Hits against Plasmodium falciparum Prolyl tRNA Synthetase Active Site and a Predicted Allosteric Site Using In Silico Approaches
por: Nyamai, Dorothy Wavinya, et al.
Publicado: (2020)

Aminoacyl-tRNA synthetases of the multi-tRNA synthetase complex and their role in tumorigenesis
por: Khan, Krishnendu, et al.
Publicado: (2022)

Aminoacyl tRNA synthetases as malarial drug targets: a comparative bioinformatics study
por: Nyamai, Dorothy Wavinya, et al.
Publicado: (2019)

Towards Novel 3-Aminopyrazinamide-Based Prolyl-tRNA Synthetase Inhibitors: In Silico Modelling, Thermal Shift Assay and Structural Studies
por: Pang, Luping, et al.
Publicado: (2021)

Repositioning and Characterization of 1-(Pyridin-4-yl)pyrrolidin-2-one Derivatives as Plasmodium Cytoplasmic Prolyl-tRNA Synthetase Inhibitors
por: Okaniwa, Masanori, et al.
Publicado: (2021)

Aminoacyl-tRNA synthetases
por: Rubio Gomez, Miguel Angel, et al.
Publicado: (2020)

Aminoacyl-tRNA synthetases, therapeutic targets for infectious diseases
por: Lee, Eun-Young, et al.
Publicado: (2018)

Tryptophanyl-tRNA Synthetase as a Potential Therapeutic Target
por: Ahn, Young Ha, et al.
Publicado: (2021)

Expanding a tyrosyl-tRNA synthetase assay to other aminoacyl-tRNA synthetases
por: Richardson, Charles J., et al.
Publicado: (2015)

Aminoacyl-tRNA Synthetases: On Anti-Synthetase Syndrome and Beyond
por: Galindo-Feria, Angeles S., et al.
Publicado: (2022)

Structural basis for the dynamics of human methionyl-tRNA synthetase in multi-tRNA synthetase complexes
por: Kim, Dong Kyu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d6ggb81rhfbepuojkp616se1o9